Chemotherapy
Induced Anemia
Market
Share, Global Trends,
Analysis, Research, Report,
Opportunities,
Segmentation and Forecast,
2016– 2026
Future Market Insights
www.futuremarketinsights.com
[email protected]
Future Market Insights (FMI) is a premier provider of syndicated research reports, custom research reports, and consulting
services. We deliver a complete packaged solution, which combines current market intelligence, statistical anecdotes,
technology inputs, valuable growth insights, aerial view of the competitive framework, and future market trends.
We provide research services at a global as well as regional level; key regions include GCC, ASEAN, and BRIC.
Our offerings cover a broad spectrum of industries including Chemicals, Materials, Energy, Technology, Healthcare, and
Retail.
We have a global presence with delivery centers across India specializing in providing global research reports and country
research reports. FMI is headquartered out of London, U.K., with a state-of-the-art delivery center located in Pune, India. We
combine our knowledge and learning from every corner of the world to distill it to one thing – the perfect solution for our
client.
Research
Capabilities




Customized
Research
Customized Research
Syndicated Research
Investment Research
Social Media Research
Sector Coverage





Automotive and Transportation

Electronics, Semiconductor, and ICT

Retail and Consumer Products

Industrial Automation and Equipment

Healthcare, Pharmaceuticals & Medical Devices
Subscription Information
Syndicated
Research
For detailed subscription information please contact
Investment
Research
T: +44 (0) 20 7692 8790 | D: +44 20 3287 4268
Social Media
Research
Hari. T (Sr. Manager - Global Business Development)
Email: [email protected]
Chemicals & Materials
Food and Beverages
Services and Utilities
Energy, Mining, Oil, and
Gas
Report
Description
Report Description
Anemia is a most common hematologic disorder in majority of cancer patients receiving
chemotherapy treatment. Anemia is a condition in which person do not have sufficient red
blood cells in the body or low ability of hemoglobin to carry oxygen and circulate it to all cells in
the body. Anemia can be caused by cancer treatment, low iron levels in body, organ problems,
chronic kidney disease and thalassemia. Moreover, some other risk factors that can develop
anemia among cancer patients are namely platinum based chemotherapy, low level of red blood
cells before having cancer and certain tumor type. To find out the cause of anemia certain tests
need to be done such as blood chemistry tests, reticulocyte count, stool test and bone marrow
exam. In Europe, the study has been conducted by European Cancer Anemia Survey (ECAS)
across 24 nations stated that around 83% of the patients going for chemotherapy demonstrated
anemia disorder. Anemia often exhibit symptoms such as fatigue, dyspnea, chest pain and fast
heartbeat. It has been estimated that about 50% of the cancer patients suffering from anemia
did not received any treatment. However, patients with head and neck cancer suffering from
anemia have risk of death is around 19% and 47% with prostate cancer patients.
Chemotherapy Induced Anemia Market:Drivers and Restraints
Chemotherapy induced anemia market are witnessing maximum growth owing to increase in
the prevalence of cancer and anemia among geriatric patients, bone marrow invasion, increase
in pipeline products, advancement in the technology, reimbursement policy and increase in
chronic inflammatory conditions..
Report
Description
Report Description
Moreover, side effects of the cancer treatment can develop anemia and increase in various
etiologies of anemia in cancer patients are some other factors expected to flourish the
chemotherapy induced anemia market. However, side effects of drugs, increase in the mortality
rate and risk associated with treatment may hamper the growth of chemotherapy induced
anemia market in near future.
Request Free Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb1757
Chemotherapy Induced Anemia Market:Segmentation
The chemotherapy induced anemia market has been classified on the basis of range of anemia,
treatment type, drug type and end user.
 Based on rang of anemia, the chemotherapy induced anemia market is segmented into the
following:
•
Mild Anemia
•
Moderate Anemia
•
Severe Anemia
•
Life-threatening Anemia
Report
Description
Report Description
 Based on treatment type, the chemotherapy induced anemia market is segmented into the
following:
•
RBC Transfusions
•
Erythropoiesis-stimulating agents (ESAs)
•
Iron Supplementation
 Based on drug type, the chemotherapy induced anemia market is segmented into the
following:
•
Epogen Injection
•
Procrit Injection
•
Androxy Oral
•
Aranesp injection
•
Epoetin Alfa Injection
•
Other
Request For TOC@ http://www.futuremarketinsights.com/toc/rep-gb-1757
 Based on end-user, the chemotherapy induced anemia market is segmented into the
following:
•
Hospitals
•
Ambulatory Surgical Centers
Report
Description
Report Description
• Multispecialty Clinics
• Cancer Research Centers
• Cancer Rehabilitation Centers
Chemotherapy Induced Anemia Market:Overview
In Japan, cancer patients with anemia disorder are treated with RBC transfusions. On the other
hand, in USA and Europe patients with chemotherapy induced anemia are treated with
erythropoiesis stimulating agents namely epoetin & darbepoetin. Fatigue is the most severe
symptoms of chemotherapy induced anemia among cancer patients and experience fatigue in
moderate to severe range of anemia. Patients received platinum, gemcitabine and anthracycline
based regimens has high chances of develop anemia.
Chemotherapy Induced Anemia Market: Region-wise Outlook
Depending on geographic region, Chemotherapy Induced Anemia Market is segmented into
seven key regions: North America, Latin America, Eastern Europe, Western Europe, Asia Pacific,
Japan, and Middle East & Africa. Asia Pacific dominates the chemotherapy induced anemia
marketfollowed by Europe, Japan and North America owing to high awareness of disease among
population, government initiatives, great advancement in the field of chemotherapy induced
anemia and developed healthcare infrastructure in these regions.
Report
Description
Report Description
Asia Pacific, Middle East and Africa hold huge potential and shows substantial growth in terms of
wide acceptance of new technologyowing to high mortality rate, prevalence of anemia among
cancer patients, increasing healthcare expenditure and high potential customer base need
treatment for chemotherapy induced anemia.
Chemotherapy Induced Anemia Market:Key Players
Key players of Chemotherapy Induced Anemia Marketare Dr. Reddy’s Laboratories Ltd., Pfizer
Inc., SBI Pharmaceuticals Co., Ltd, Panacea Biotec Limited, Panacea Biotec., 3SBio Inc., Tolero
Pharmaceuticals, Inc., Vifor Pharma AG and Therapure Biopharma Inc.
Thank You!
To know more about us, please visit our website:
www.futuremarketinsights.com
For sales queries or new topics email us on:
[email protected]
For other queries contact:
Future Market Insights: 616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States
T: +1-347-918-3531 | D: +1-845-579-5705